You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Losartan reduces aortic dilatation rate in adults with Marfan syndrome: a randomized controlled trial
|
---|---|
Published in |
European Heart Journal, September 2013
|
DOI | 10.1093/eurheartj/eht334 |
Pubmed ID | |
Authors |
Maarten Groenink, Alexander W. den Hartog, Romy Franken, Teodora Radonic, Vivian de Waard, Janneke Timmermans, Arthur J. Scholte, Maarten P. van den Berg, Anje M. Spijkerboer, Henk A. Marquering, Aeilko H. Zwinderman, Barbara J.M. Mulder |
Abstract |
Patients with Marfan syndrome have an increased risk of life-threatening aortic complications, mostly preceded by aortic dilatation. Treatment with losartan, an angiotensin-II receptor-1 blocker, may reduce aortic dilatation rate in Marfan patients. |
X Demographics
The data shown below were collected from the profiles of 19 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 4 | 21% |
Venezuela, Bolivarian Republic of | 1 | 5% |
Ecuador | 1 | 5% |
United Kingdom | 1 | 5% |
Brazil | 1 | 5% |
Unknown | 11 | 58% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 14 | 74% |
Practitioners (doctors, other healthcare professionals) | 4 | 21% |
Science communicators (journalists, bloggers, editors) | 1 | 5% |
Mendeley readers
The data shown below were compiled from readership statistics for 208 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Netherlands | 3 | 1% |
United Kingdom | 1 | <1% |
Canada | 1 | <1% |
New Zealand | 1 | <1% |
Singapore | 1 | <1% |
Russia | 1 | <1% |
Spain | 1 | <1% |
Greece | 1 | <1% |
Unknown | 198 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 33 | 16% |
Student > Ph. D. Student | 24 | 12% |
Other | 21 | 10% |
Student > Bachelor | 21 | 10% |
Student > Doctoral Student | 20 | 10% |
Other | 55 | 26% |
Unknown | 34 | 16% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 115 | 55% |
Biochemistry, Genetics and Molecular Biology | 18 | 9% |
Agricultural and Biological Sciences | 15 | 7% |
Nursing and Health Professions | 5 | 2% |
Engineering | 4 | 2% |
Other | 11 | 5% |
Unknown | 40 | 19% |
Attention Score in Context
This research output has an Altmetric Attention Score of 15. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 March 2022.
All research outputs
#2,282,004
of 24,598,501 outputs
Outputs from European Heart Journal
#2,903
of 10,705 outputs
Outputs of similar age
#19,607
of 203,834 outputs
Outputs of similar age from European Heart Journal
#26
of 121 outputs
Altmetric has tracked 24,598,501 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 90th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,705 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 32.0. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 203,834 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 121 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 79% of its contemporaries.